Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Directed Topical Drug Delivery for Treatment for PASC Hyposmia

NCT05970731 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT05970731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05970731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Directed Topical Drug Delivery for Treatment for PASC Hyposmia
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
September 5, 2023
Completion date
October 7, 2024
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post acute sequelae covid-19 hyposmia